Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids.

Nona Biosciences (Nasdaq: NONA) has introduced Hu-mAtrIx, an artificial intelligence (AI)-assisted drug discovery platform designed to accelerate the identification and development of antibody-based ...

Harrison's plasma contained the rare antibody Anti-D, also known as Rhesus D antibody, which is used to make the medication given to mothers whose blood is at risk of attacking their fetuses.

Pri­vate start­up Sor­riso Phar­ma­ceu­ti­cals laid out Phase 1b da­ta at a med­ical con­fer­ence last week­end as part of its ef­fort to bring an oral an­ti­body … ...

The rapid spread of SARS-CoV-2 and its continuing impact on human health has prompted the need for effective and rapid development of monoclonal antibody therapeutics ... using an in-house variant of ...

AIH type 3 is serologically defined by the presence of SLA/LP autoantibodies. However, 74% of patients also have other serological markers of autoimmunity, including SMA and AMA. AIH type 3 has a ...

Future studies utilizing needle biopsy samples from mild and moderate alcoholic hepatitis patients could assess infiltration of B and plasma cells and a likely correlation between antibody deposition ...

Through its proprietary EEV platform, Entrada is building a development portfolio of oligonucleotide, antibody and enzyme-based programs for the potential treatment of neuromuscular diseases, ...